Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer

SIMPLE SUMMARY: Breast cancer (BC) is a common malignancy with molecular diversity, i.e., heterogeneity. Aside from routine clinical treatments, such as chemotherapy and radiotherapy, which have side effects and tumor resistance, troubling patients and doctors, targeted therapy based on molecular cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaolu, Liu, Kuai, Lu, Shuli, He, Weina, Du, Zixiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656512/
https://www.ncbi.nlm.nih.gov/pubmed/36358874
http://dx.doi.org/10.3390/cancers14215456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656512/
https://www.ncbi.nlm.nih.gov/pubmed/36358874
http://dx.doi.org/10.3390/cancers14215456

Ejemplares similares